The levonogestrel-releasing intrauterine device and endometrial cancer: a potential opportunity for young women
Russo, V.; Prota, G.; Trapasso, S.; La Ferrera, N.
Minerva Ginecologica 66(1): 129-130
2014
ISSN/ISBN: 1827-1650 PMID: 24569411 Document Number: 672593
Document emailed within 1 workday
Related Documents
Vandenput, I.; Van Eygen, K.; Moerman, P.; Vergote, I.; Amant, F. 2009: Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature European Journal of Gynaecological Oncology 30(3): 313-316Guleria, K.; Agarwal, N.; Mishra, K.; Gulati, R.; Mehendiratta, A. 2004: Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer? Journal of Obstetrics and Gynaecology Research 30(3): 181-187
Archer, D.F.; Desoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-α concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone : A possible mechanism of action of the intrauterine device Contraception (Stoneham) 59(3): 175-179
Archer, D.F.; DeSoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. a possible mechanism of action of the intrauterine device Contraception 59(3): 175-179
El Behery, M.M.; Saleh, H.S.; Ibrahiem, M.A.; Kamal, E.M.; Kassem, G.A.; Mohamed, M.E.S. 2015: Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia Reproductive Sciences 22(3): 329-334
Munteanu, O.; Cirstoiu, M.; Antoniac, I.; Cirstoiu, C. 2016: Comparison of Pain Level During and After Intrauterine Device Insertion: Levonorgestrel-Releasing Intrauterine System Versus the Copper T Intrauterine Device Environmental Engineering and Management Journal 15(5): 965-972
Hawkes, A.L.; Quinn, M.; Gebski, V.; Armes, J.; Brennan, D.; Janda, M.; Obermair, A. 2014: Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial Contemporary Clinical Trials 39(1): 14-21
Vaughan, D.; Byrne, P. 2012: An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 32(4): 372-374
Bourdrez, P.; Bongers, M.Y.; Mol, B.W.J. 2004: Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy Fertility and Sterility 82(1): 160-6 Quiz 265
Imperato, F.; Perniola, G.; Mossa, B.; Marziani, R.; Perniola, F.; Stragapede, B.; Napolitano, C. 2002: The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years) Minerva Ginecologica 54(3): 271-278
Kim, M.K.; Seong, S.J.; Kim, Y.S.; Song, T.; Kim, M.-L.; Yoon, B.S.; Jun, H.S.; Lee, Y.H. 2013: Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer American Journal of Obstetrics and Gynecology 209(4): 358.E1-4
Xie, Z.-W.; Zhang, Y.-N.; Wan, S.; Xu, W.-Z.; Chen, J. 2012: Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma Journal of International Medical Research 40(5): 1966-1972
Akintomide, H.; James, A.; Moffat, M.; Barnes, P.; Rankin, J. 2022: Systematic review of copper intrauterine contraception continuation in young nulliparous women based on intrauterine device type Bmj Open 12(10): E060606
Akintomide, H.; James, A.; Moffat, M.; Barnes, P.; Rankin, J. 2022: Systematic review of copper intrauterine contraception continuation in young nulliparous women based on intrauterine device type Bmj Open 12(10): E060606
Brown, A.J.; Westin, S.N.; Broaddus, R.R.; Schmeler, K. 2012: Progestin intrauterine device in an adolescent with grade 2 endometrial cancer Obstetrics and Gynecology 119(2 Part 2): 423-426
Jóźwik, M.; Jóźwik, M.; Modzelewska, B.; Niewińska, M.; Jóźwik, Mł. 2015: Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women Ginekologia Polska 86(4): 305-310
Heikkilä, M. 1982: Puerperal insertion of a copper-releasing and a levonorgestrel-releasing intrauterine contraceptive device Contraception 25(6): 561-572
Herman, M.C.; van den Brink, M.J.; Geomini, P.M.; van Meurs, H.S.; Huirne, J.A.; Eising, H.P.; Timmermans, A.; Pijnenborg, J.M.A.; Klinkert, E.R.; Coppus, S.F.; Nieboer, T.E.; Catshoek, R.; van der Voet, L.F.; van Eijndhoven, H.W.F.; Graziosi, G.C.M.; Veersema, S.; van Kesteren, P.J.; Langenveld, J.; Smeets, N.A.C.; van Vliet, H.A.A.M.; van der Steeg, J.W.; Lisman-van Leeuwen, Y.; Dekker, J.H.; Mol, B.W.; Berger, M.Y.; Bongers, M.Y. 2013: Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial Bmc Women's Health 13: 32
Gordon, L. 2020: 36. Lessons from Intrauterine Device (IUD) IUD Contraceptive Failure in Young Women Journal of Pediatric and Adolescent Gynecology 33(2): 192-193
Rana, M.; Saxena, P.; Firdous, N. 2012: Comparison of levonorgestrel and copper releasing intrauterine contraceptive device on body iron stores and menstrual bleeding patterns: experience on Indian women European Review for Medical and Pharmacological Sciences 16(2): 230-234